Annual Accounts Receivable
$10.67 M
-$4.52 M-29.74%
September 30, 2023
Summary
- As of February 8, 2025, UPC annual accounts receivable is $10.67 million, with the most recent change of -$4.52 million (-29.74%) on September 30, 2023.
- During the last 3 years, UPC annual accounts receivable has fallen by -$204.20 thousand (-1.88%).
- UPC annual accounts receivable is now -31.50% below its all-time high of $15.57 million, reached on September 30, 2021.
Performance
UPC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$14.38 M
+$3.72 M+34.84%
March 31, 2024
Summary
- As of February 8, 2025, UPC quarterly accounts receivable is $14.38 million, with the most recent change of +$3.72 million (+34.84%) on March 31, 2024.
- Over the past year, UPC quarterly accounts receivable has dropped by -$3.14 million (-17.90%).
- UPC quarterly accounts receivable is now -23.55% below its all-time high of $18.82 million, reached on March 31, 2022.
Performance
UPC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
UPC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | -17.9% |
| 3 y3 years | -1.9% | -19.2% |
| 5 y5 years | +39.7% | - |
UPC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.5% | at low | -23.6% | +34.8% |
| 5 y | 5-year | -31.5% | +66.1% | -23.6% | +227.7% |
| alltime | all time | -31.5% | +66.1% | -23.6% | +227.7% |
Universe Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $14.38 M(+34.8%) |
| Sep 2023 | $10.67 M(-29.7%) | $10.67 M(-39.1%) |
| Mar 2023 | - | $17.52 M(+15.4%) |
| Sep 2022 | $15.18 M(-2.5%) | $15.18 M(-19.3%) |
| Mar 2022 | - | $18.82 M(+20.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | $15.57 M(+43.2%) | $15.57 M(-12.5%) |
| Mar 2021 | - | $17.80 M(+63.7%) |
| Sep 2020 | $10.87 M(+69.3%) | $10.87 M(+147.7%) |
| Mar 2020 | - | $4.39 M(-31.6%) |
| Sep 2019 | $6.42 M(-15.9%) | $6.42 M |
| Sep 2018 | $7.64 M | - |
FAQ
- What is Universe Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals annual accounts receivable year-on-year change?
- What is Universe Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Universe Pharmaceuticals?
- What is Universe Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Universe Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of UPC is $10.67 M
What is the all time high annual accounts receivable for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high annual accounts receivable is $15.57 M
What is Universe Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, UPC annual accounts receivable has changed by -$4.52 M (-29.74%)
What is Universe Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of UPC is $14.38 M
What is the all time high quarterly accounts receivable for Universe Pharmaceuticals?
Universe Pharmaceuticals all-time high quarterly accounts receivable is $18.82 M
What is Universe Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, UPC quarterly accounts receivable has changed by -$3.14 M (-17.90%)